Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
University of Texas
Helpful Links
 

62nd Pharmacy Practice Seminar • PPS • Austin, TX


pps conference

This is our 2nd year using the New Registration System!  

For detail information regarding PPS, please visit the main website:  http://www.utexas.edu/pharmacy/ce/conferences/pps/index.html

•   If you attended PPS last year, then you should already have a profile in the system and you can use that to register.

•   If you do not remember the email you used or password, use the options listed on the log-in page to have the system send that information.

 

Date: Sep 13, 2014 07:00 AM - Sep 14, 2014 04:00 PM

Fee

$425.00

CE Hours

15.00

CE Units

1.500

Registration closes on Oct 30, 2014

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
 

Requirements for CE Credit

To Receive Continuing Education Credit
 
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This two-day activity is approved for 1.5 CEUs (15 contact hours) of continuing education credit.  In order to receive 15 contact hours of CE credit, the participant must attend/participate in all sessions of the program, and return their completed Record of Attendance/Evaluation Forms at the conclusion of the program.
 

 

 

Registration Closed  

Date: 09/13/14
Time: 07:30 AM - 07:45 AM
Registration Closed  

Registration Closed  

Speaker(s)/Author(s)

William Riffee picture

William Riffee, BSPharm., Ph.D.
Professor and Dean of UF Pharmacy, University of Flordia

Activity Number

0067-0000-14-010-L04-P/T
Date: 09/13/14
Time: 07:45 AM - 09:00 AM

CE Hours

1.25
Registration Closed  

Registration Closed  

Objectives

  • Define new pregnancy risks categories.
  • Describe how to identify the teratogenicity of medications.
  • Identify medications that should be avoided during pregnancy and lactation.
  • Discuss approaches to counseling about medications for which no human pregnancy data exists.

Speaker(s)/Author(s)

Thomas Hale picture

Thomas Hale, R.Ph., Ph.D.
Texas Tech University Health Sciences Center

Activity Number

0067-0000-14-011-L01-P/T
Date: 09/13/14
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Review recent developments in anticoagulation therapy
  • List the key prescribing points, safety concerns, and monitoring parameters for each anticoagulant.
  • Identify options for reversing anticoagulants.
  • Discuss switching between anticoagulation agents.

Speaker(s)/Author(s)

Bryson Duhon, Pharm.D. picture

Bryson Duhon, Pharm.D.
Clinical Assistant Professor, The University of Texas at Austin College of Pharm

Activity Number

0067-0000-14-012-L01-P/T
Date: 09/13/14
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Explain how the Affordable Care Act will impact current pharmacy practice.
  • Recognize the impact the Affordable Care Act may have on consumers, insurance companies, and small business.

Speaker(s)/Author(s)

David Warner, PhD picture

David Warner, PhD
LBJ School of Public Affairs, UT Austin

Activity Number

0067-0000-14-013-L03-P/T
Date: 09/13/14
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Interpret new lipid recommendations using patient case studies.
  • Interpret new hypertension recommendations using patient case studies.
  • Describe evidence-based treatment strategies for hypertension and hyperlipidemia based on case studies.

Speaker(s)/Author(s)

James A. Karboski picture

James A. Karboski, Pharm.D.
Clinical Associate Professor, The University of Texas at Austin College of Pharm

Activity Number

0067-0000-14-014-L01-P/T
Date: 09/13/14
Time: 01:00 PM - 02:00 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the pharmacology, adverse effects, drug interactions therapeutic uses and dosing of selected prescription drugs recently marketed.

Speaker(s)/Author(s)

Leroy C. Knodel picture

Leroy C. Knodel, Pharm.D.
Clinical Professor & Associate Professor, UT Austin College of Pharmacy / UTHSCSA

Activity Number

0067-0000-14-015-L01-P/T
Date: 09/13/14
Time: 02:00 PM - 03:15 PM

CE Hours

1.25
Registration Closed  

Registration Closed  

Objectives

  • Examine the changes and challenges that affect the relationships between Alzheimer's patients and their family/loved ones.
  • Describe community-based, long-term services that are available for Alzheimer's patients.
  • Identify resources and services to recommend to caregivers of Alzheimer's patients.

Speaker(s)/Author(s)

Jennifer Scott
Director of Again Services, Area Agency on Aging of the Capital Area

Activity Number

0067-0000-14-016-L01-P/T
Date: 09/13/14
Time: 03:30 PM - 04:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the practical goals of an antimicrobial stewardship.
  • Discuss local applications of such stewardships, for both community and institutional settings.
  • Review current prophylactic antibiotic measures seen in practice.

Speaker(s)/Author(s)

Elizabeth O. Hand, Pharm.D., BCPS picture

Elizabeth O. Hand, Pharm.D., BCPS
Clinical Assistant Professor - Pediatrics, The University of Texas at Austin College of Pharm

Activity Number

0067-0000-14-017-L03-P/T
Date: 09/13/14
Time: 04:45 PM - 05:45 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Date: 09/13/14
Time: 05:45 PM - 05:45 PM
Registration Closed  

 

Registration Closed  

Date: 09/14/14
Time: 07:30 AM - 08:00 AM
Registration Closed  

Registration Closed  

Objectives

  • Describe the pathophysiology of Rheumatoid Arthritis (RA), including any characteristic clinical features.
  • Discuss current therapies used to decrease the progression of RA.

Speaker(s)/Author(s)

Christopher Parker, D.O., FACP, FACR
Rheumatology Service, Austin Diagnostic Clinic

Activity Number

0067-0000-14-018-L01-P/T
Date: 09/14/14
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Cite recent changes in pharmacy laws and rules and their impact on daily practice.
  • Critically discuss practice scenarios regarding Texas pharmacy laws ad rules.

Speaker(s)/Author(s)

Gay Dodson picture

Gay Dodson, R.Ph.
Executive Director / Secretary , Texas State Board of Pharmacy

Activity Number

0067-0000-14-019-L03-P/T
Date: 09/14/14
Time: 09:15 AM - 11:00 AM

CE Hours

1.50
Registration Closed  

Registration Closed  

Objectives

  • Explain the reasons behind abuse deterrent opioid formulations.Identify the requirements for abuse deterrent opioid formulations.
  • Identify the requirements for abuse deterrent opioid formulations.
  • Identify the methods used to create abuse deterrent formulations.
  • Identify the methods of studying abuse deterrent formulations.

Speaker(s)/Author(s)

Laurajo Ryan picture

Laurajo Ryan, Pharm.D., MSc, BCPS, CDE
Clinical Associate Professor, UT Austin College of Pharmacy / UTHSCSA


Brief Bio : Ryan practices in the area of Adult Internal Medicine, primarily in the acute treatment of the hospitalized patient. Her principal interests include diabetes, nutrition and cirrhosis.

Activity Number

0067-0000-14-020-L01-P/T
Date: 09/14/14
Time: 10:45 AM - 11:45 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Define the pathophysiology and diagnosis of celiac disease.
  • Recognize signs and symptoms of celiac disease and referral opportunities.
  • Identify potential sources of gluten in medications.

Speaker(s)/Author(s)

Harish Gagneja, MD, AGAF picture

Harish Gagneja, MD, AGAF
Austin Gastroenterology

Activity Number

0067-0000-14-021-L01-P/T
Date: 09/14/14
Time: 12:45 PM - 01:45 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Low testosterone - real diagnosis or not
  • Benign Prostatic Hyperplasia- Identify medications and when to treat
  • Update on the utility of Prostate- Specific Antigen (PSA)
  • Erectile Dysfunction (ED) update

Speaker(s)/Author(s)

Bryan Kansas picture

Bryan Kansas, MD
The Urology Team

Activity Number

0067-0000-14-022-L01-P/T
Date: 09/14/14
Time: 01:45 PM - 02:45 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Define Traumatic Brain Injury (TBI) and some common causes.
  • Identify signs and symptoms associated with TBI.
  • Discuss the management of TBI, both short-term and long-term.
  • Describe Texas law requiring evaluation for concussion and ho it impacts patient care.

Speaker(s)/Author(s)

Kimberly Arlinghaus, MD picture

Kimberly Arlinghaus, MD
Medical Director of Psychiatry and Behavioral Health, Lone Star Circle of Care

Activity Number

0067-0000-14-023-L01-P/T
Date: 09/14/14
Time: 02:45 PM - 02:00 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Date: 09/14/14
Time: 03:45 PM - 03:45 PM
Registration Closed